CAN SPECIALISED NUTRITION IMPACT SURVIVAL?

ESPEN 2016,
Copenhagen, Denmark
Why You Can’t Afford to Ignore Malnutrition: New HEOR Insights

Scott Goates, PhD
Abbott Nutrition Research and Development
Columbus, Ohio, USA

Dr. Goates describes a health economics and outcomes research (HEOR) analysis of estimated lifetime data from the multicenter, randomized, placebo-controlled clinical trial of oral nutritional supplementation with high protein and β-hydroxy-β-methylbutyrate (HP-HMB) in malnourished, older, hospitalized patients (The NOURISH Study). Careful modeling of healthcare costs and benefits demonstrates that the HP-HMB intervention is cost-effective, extends lives, and compares favorably with other low cost, low risk interventions, such as aspirin for the prevention of cardiovascular disease or flu vaccinations.

NOURISH = Nutrition effect On Unplanned ReadmIssions and Survival in Hospitalized patients

Why You Can’t Afford to Ignore Malnutrition: New HEOR Insights
Why You Can’t Afford to Ignore Malnutrition: New HEOR Insights
Scott Goates, PhD

Additional Recommended Content

Inborn Errors of Metabolism: A Snapshot
Courtney Allgeier, MS, RD, LD
Oncology Quality of Life
Tiffany DeWitt MS, MBA, RD, LD

*at no charge